Stay updated on Pembrolizumab for Rare Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Rare Tumors Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, indicating a new build or patch of the site or documentation rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-08-10T11:50:03.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The revision tag was updated from v3.6.3 to v3.6.4. This appears to be a minor software update with no evident changes to content or user-facing features in the provided context.
    Difference
    0.0%
    Check dated 2026-07-27T06:39:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's update dates were refreshed in July 2026, replacing earlier January 2026 timestamps. This reflects routine maintenance to keep the study record's metadata current.
    Difference
    0.2%
    Check dated 2026-07-20T02:13:24.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a new revision tag, Revision: v3.6.3, replacing the previous v3.6.2. This indicates a new build of the page content without changing the study details themselves.
    Difference
    0.0%
    Check dated 2026-07-05T14:34:38.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new publication citation by Derbala et al. was added to the study's Publications, documenting AI-guided analysis predicting pembrolizumab response in rare tumors. The page revision was updated to v3.6.2, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-28T08:47:03.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Added user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and a recruitment status note ('No longer looking for participants'), reflecting a change in participant availability. Updated the Interventions label from 'Intervention / Treatment' to 'Intervention/Treatment' and added a new revision (Revision: v3.6.0) while removing the older label (Revision: v3.5.5).
    Difference
    0.4%
    Check dated 2026-06-14T05:41:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Rare Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Rare Tumors Clinical Trial page.